US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

Nektar Says Eli Lilly Botched Autoimmune Drug Trials

By Ayden Crosby · August 7, 2023, 7:47 PM EDT

Nektar Therapeutics is accusing Eli Lilly of butchering and delaying clinical trials for a new autoimmune-disease drug the two companies agreed to develop together, claiming the pharma giant ruined the drug's...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

Nektar Therapeutics v. Eli Lilly & Co

Case Number

3:23-cv-03943

Court

California Northern

Nature of Suit

Contract: Other

Date Filed

August 07, 2023

Featured Stories

'Secret Shoppers' Get ACA Plan Runaround No Photo Available

Dan McKay

Georgetown University researchers shopping incognito for Affordable Care Act insurance plans found misleading claims and even outright... (more story)

Courts Rule On GLP-1 Shortage Row, 340B In Colo. And More No Photo Available

Gianna Ferrarin

Law360 Healthcare Authority looks at a Fifth Circuit ruling backing the removal of certain GLP-1 medications from the national drug sh... (more story)

3 Things To Know: Texas Judge Halts Abortion Drug Suit No Photo Available

Mark Payne

A Texas federal judge has paused a lawsuit challenging the U.S. Food and Drug Administration's approval of abortion medication mifepri... (more story)